1. Neumann F.J., Sousa-Uva M., Ahlsson A., Alfonso F., Banning A.P., Benedetto U., et al.: 2018 ESC/ EACTS Guidelines on myocardial revascularization. Eur Heart J. 2019; 40 (2): 87–165.
2. Baumgartner H., Falk V., Bax J.J., De Bonis M., Hamm C., Holm P.J., et al.: 2017 ESC/EACTS Guidelines for the management of valvular heart disease. Eur Heart J. 2017; 38 (36): 2739–2791.
3. Hays R.D.: The Medical Outcomes Study (MOS) Measures of Patient Adherence. Retrieved April 19, 2004, from the RAND Corporation web site: http://www.rand.org/health/surveys/MOS.adherence.measures.pdf.
4. Cerqueira M., Weissman N., Dilsizian V., et al.: Standardized myocardial segmentation and nomenclature for tomographic imaging of the heart. Circulation. 2002; 105 (4): 539–542.
5. Lang R., Bierig M., Devereux R., et al.: Recommendations for Chamber Quantification: A Report from the American Society of Echocardiography’s Guidelines and Standards Committee and the Chamber Quantification Writing Group, Developed in Conjunction with the European Association of Echocardiography, a Branch of the European Society of Cardiology. J Am Soc Echocardiogr. 2005; 18: 1440–1463.
6. Yiu S.F., Enriquez-Sarano M., Tribouilloy C., Seward J.B., Tajik A.J.: Determinants of the degree of functional mitral regurgitation in patients with systolic left ventricular dysfunction: A quantitative clinical study. Circulation 2000; 102: 1400–1406.
7. Srichai M.B., Grimm R.A., Stillman A.E., Gillinov A.M., Rodriguez L.L., Lieber M.L., et al.: Ischemic mitral regurgitation: impact of the left ventricle and mitral valve in patients with left ventricular systolic dysfunction. Ann Thorac Surg. 2005;80 (1): 170–178.
8. Kang D.H., Kim M.J., Kang S.J., Song J.M., Song H., Hong M.K., et al.: Mitral valve repair versus revascularization alone in the treatment of ischemic mitral regurgitation. Circulation. 2006; 114 (1 Suppl): I499–I503.
9. Kim B.J., Kim Y.S., Kim H.J., Ju M.H., Kim J.B., Jung S.H., et al.: Concomitant mitral valve surgery in patients with moderate ischemic mitral regurgitation undergoing coronary artery bypass grafting. J Thorac Dis. 2018; 10 (6): 3632–3642.
10. Bouchard D., Jensen H., Carrier M., Demers P., Pellerin M., Perrault L.P., et al.: Effect of systematic downsizing rigid ring annuloplasty in patients with moderate ischemic mitral regurgitation. J Thorac Cardiovasc Surg. 2014; 147 (5): 1471–1477.
11. Chan K.M., Punjabi P.P., Flather M., Wage R., Symmonds K., Roussin I., et al.: Coronary artery bypass surgery with or without mitral valve annuloplasty in moderate functional ischemic mitral regurgitation: final results of the Randomized Ischemic Mitral Evaluation (RIME) trial. Circulation. 2012; 126 (21): 2502–2510.
12. Fattouch K., Guccione F., Sampognaro R., Panzarella G., Corrado E., Navarra E., et al.: POINT: Efficacy of adding mitral valve restrictive annuloplasty to coronary artery bypass grafting in patients with moderate ischemic mitral valve regurgitation: a randomized trial. J Thorac Cardiovasc Surg. 2009; 138 (2): 278–285.
13. Borger M.A., Alam A., Murphy P.M., Doenst T., David T.E.: Chronic ischemic mitral regurgitation: repair, replace or rethink? Ann Thorac Surg. 2006; 81 (3): 1153–1161.
14. Sundt T.M.: Surgery for ischemic mitral regurgitation. N Engl J Med. 2014; 371 (23): 2228–2289.
15. Wagner A.K., Gandek B., Aaronson N.K., et al.: Cross-cultural comparison of the content of SF-36 translations across 10 countries: result from the IQOLA Project. International Quality of Life Assessment. J Clin Epidemiol 1998; 51: 925–932.
16. Simchen E., Galai N., Braun D., et al.: Sociodemographic and clinical factors associated with low quality of life one year after coronary bypass operations: the Israeli coronary artery bypass study (ISCAB). J Thorac Cardiovasc Surg. 2001; 121: 909–919.
17. Permanyer M., Brotons C., Cascant P., et al.: Assessment of quality of life related health 2 years after coronary surgery. Med Clin (Barc). 1997; 108: 446–451.
18. Al-Ruzzeh S., Athanasiou T., Mangoush O., Wray J., Modine T., George S., Amrani M.: Predictors of poor mid-term health related quality of life after primary isolated coronary artery bypass grafting surgery. Heart. 2005 Dec; 91 (12): 1557–1562.
19. Westlake C., Dracup K., Creaser J., et al.: Correlates of health-related quality of life in patients with heart failure. Heart Lung 2002; 31: 85–93.
20. Smith P.K., Puskas J.D. Ascheim D.D., Voisine P., Gelijns A.C., Moskowitz A.J., et al.: Surgical treatment of moderate ischemia mitral regurgitation. N Engl J Med. 2014; 371: 2178–2188.
21. Baig K., Harling L., Papanikitas J., Attaran S., Ashrafian H., Casula R., et al.: Does coronary artery bypass grafting improve quality of life in elderly patients? Interact Cardiovasc Thorac Surg. 2013; 17 (3): 542–553.
22. Jokinen J.J., Hippeläinen M.J., Turpeinen A.K., Pitkänen O., Hartikainen J.E.: Health-related quality of life after coronary artery bypass grafting: a review of randomized controlled trials. J Card Surg. 2010; 25 (3): 309–317.
23. Dunning J., Waller J.R., Smith B., Pitts S., Kendall S.W., Khan K.: Coronary artery bypass grafting is associated with excellent long-term survival and quality of life: a prospective cohort study. Ann Thorac Surg. 2008; 85: 1988–1993.
24. Rijnhart-de Jong H., Haenen J., Bol Raap G., et al.: Determinants of non-recovery in physical health- related quality of life one year after cardiac surgery: a prospective single Centre observational study. J Cardiothorac Surg. 2020; 15 (1): 234. doi: 10.1186/s13019-020-01273-1